LON:VRP - Verona Pharma Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Verona Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 55 -1.50 (-2.65 %) (As of 01/28/2020 04:00 PM ET) Add Compare Today's Range 53Now: GBX 55▼ 57.8050-Day Range 38.50MA: GBX 53.75▼ 7552-Week Range 37.15Now: GBX 55▼ 102Volume142,800 shsAverage Volume49,797 shsMarket Capitalization£57.93 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Read More… Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:VRP Previous Symbol CUSIPN/A CIKN/A Webhttp://www.veronapharma.com/ Phone+44-20-32834200Debt Debt-to-Equity Ratio2.68 Current Ratio4.07 Quick Ratio3.79Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 37.63 per share Price / Cash Flow1.46 Book ValueGBX 38.20 per share Price / Book1.44Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees22 Outstanding Shares105,327,000Market Cap£57.93 million Next Earnings DateN/A OptionableOptionable Receive VRP News and Ratings via Email Sign-up to receive the latest news and ratings for VRP and its competitors with MarketBeat's FREE daily newsletter. LSE:VRP Rates by TradingView Verona Pharma (LON:VRP) Frequently Asked Questions What is Verona Pharma's stock symbol? Verona Pharma trades on the London Stock Exchange (LON) under the ticker symbol "VRP." How were Verona Pharma's earnings last quarter? Verona Pharma Plc (LON:VRP) announced its quarterly earnings data on Tuesday, August, 6th. The company reported ($13.65) earnings per share for the quarter. View Verona Pharma's Earnings History. What is the consensus analysts' recommendation for Verona Pharma? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Verona Pharma in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Verona Pharma. Has Verona Pharma been receiving favorable news coverage? News headlines about VRP stock have trended somewhat negative this week, according to InfoTrie. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Verona Pharma earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Verona Pharma. Who are some of Verona Pharma's key competitors? Some companies that are related to Verona Pharma include Enochian Biosciences (ENOB), Horizon Discovery Group (HZD), Exicure (XCUR), IMV (IMV), Bioventix (BVXP), Ergomed (ERGO), CorMedix (CRMD), Helix Biopharma (HBP), CorMedix (CRMD), Senesco Technologies (ELOX), Burcon NutraScience (BU), Trillium Therapeutics (TRIL), Fennec Pharmaceuticals (FRX), OncoCyte (OCX) and Lineage Cell Therapeutics (LCTX). What other stocks do shareholders of Verona Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Verona Pharma investors own include Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), VERONA PHARMA P/S (VRNA), Madalena Energy (MVN), BioMarin Pharmaceutical (BMRN), Exelixis (EXEL), Amicus Therapeutics (FOLD), Global Blood Therapeutics (GBT), GRIFOLS S A/S (GRFS) and Innoviva (INVA). Who are Verona Pharma's key executives? Verona Pharma's management team includes the folowing people: Dr. Jan-Anders Karlsson, CEO & Exec. Director (Age 64)Mr. Piers John Morgan, Chief Financial Officer (Age 53)Ms. Claire Louise Poll L.C.S.W., B.A., B Juris, LLB, ASIA, Gen. Counsel (Age 52)Ms. Victoria Stewart, Director of CommunicationsDr. Peter Spargo, Sr. VP of Chemistry Manufacturing & Controls (Age 57) How do I buy shares of Verona Pharma? Shares of VRP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Verona Pharma's stock price today? One share of VRP stock can currently be purchased for approximately GBX 55. How big of a company is Verona Pharma? Verona Pharma has a market capitalization of £57.93 million. Verona Pharma employs 22 workers across the globe.View Additional Information About Verona Pharma. What is Verona Pharma's official website? The official website for Verona Pharma is http://www.veronapharma.com/. How can I contact Verona Pharma? Verona Pharma's mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The company can be reached via phone at +44-20-32834200. MarketBeat Community Rating for Verona Pharma (LON VRP)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 218 (Vote Outperform)Underperform Votes: 233 (Vote Underperform)Total Votes: 451MarketBeat's community ratings are surveys of what our community members think about Verona Pharma and other stocks. Vote "Outperform" if you believe VRP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/28/2020 by MarketBeat.com StaffFeatured Article: What is a back-end load?
